SEALANT KIT, HEMOSTA

The contract is for a Hemostatic Matrix Floseal Sealant Kit, a medical device intended as an adjunct to hemostasis during surgical procedures outside ophthalmology when traditional methods like ligation are ineffective or impractical. The kit contains a bovine-derived gelatin matrix, recombinant human thrombin, applicator tips, mixing accessories, a syringe for matrix preparation, and a vial adapter for needle-free reconstitution with 0.9% sodium chloride solution. It is explicitly labeled as non-latex, non-DEHP, and non-PVC with a strict 24-month non-extendable shelf life, classifying it as a Type I (Code M) item under DLA shelf-life regulations. The unit of issue is one package containing six units, and the delivery is required 20 days after award to a designated location in San Antonio, Texas, under FOB Destination terms, with government acceptance occurring at the delivery point. The National Stock Number is 6515-01-723-0313, and the solicitation number is SPE2DS-26-T-076N, with a response deadline of May 26, 2026. Compliance with stringent packaging and labeling standards is mandatory, governed by Medical Marking Standard No. 1 (MMS No. 1) which supersedes MIL-STD-129 for medical items, along with MIL-STD-2073-1E for packaging methods and DLA’s RP001 packaging requirements. Items must be bar-coded with NSN, CAGE code, contract number, and quantity, and labeled as per FDA requirements and Hazard Communication Standard (29 CFR 1910.1200), with exemptions noted where applicable. Technical and quality requirements from the DLA Master List are incorporated by reference, including RA001, RS016, RD003, RP001, and RQ011. The contract includes multiple Federal Acquisition Regulation clauses covering trafficking in persons, employment eligibility, sustainable products, hazardous materials, cyber security, whistleblower protections, and prohibition of defense telecommunications equipment from Chinese military companies. All proposals must be submitted electronically via DIBBS, and the award is subject to compliance with small business representation requirements, Unique Entity Identifiers, and socioeconomic certifications. Electronic invoicing through WAWF is required, and the Department of Defense Medical Supply Chain is the proc